New Risk • Jun 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (₩12.3b market cap, or US$7.92m). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (22% increase in shares outstanding). New Risk • Jun 24
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩14.1b (US$9.14m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (₩14.1b market cap, or US$9.14m). Minor Risk Shareholders have been diluted in the past year (22% increase in shares outstanding). Announcement • Feb 24
TASCOM Co.,Ltd., Annual General Meeting, Mar 26, 2026 TASCOM Co.,Ltd., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 268, hagui-ro, dongan-gu, gyeonggi-do, anyang South Korea New Risk • Jan 22
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (26% increase in shares outstanding). Market cap is less than US$100m (₩20.0b market cap, or US$13.6m). New Risk • Dec 22
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩13.1b (US$8.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Market cap is less than US$10m (₩13.1b market cap, or US$8.85m). New Risk • Aug 29
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩13.6b (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (₩13.6b market cap, or US$9.80m). Minor Risk Share price has been volatile over the past 3 months (9.7% average weekly change). New Risk • Jul 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Market cap is less than US$100m (₩18.0b market cap, or US$12.9m). New Risk • May 16
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₩19.7b market cap, or US$14.1m). New Risk • May 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩17.3b market cap, or US$12.4m). Announcement • Mar 15
TASCOM Co., Ltd. announced that it has received KRW 300 million in funding On March 13, 2025, TASCOM Co., Ltd. closed the transaction. Announcement • Mar 14
TASCOM Co., Ltd. announced that it expects to receive KRW 300 million in funding TASCOM Co., Ltd. announced a private placement of series 3 Unregistered unsecured private placement convertible bonds with bearer interest for gross proceeds of KRW 300,000,000 on March 12, 2025. The transaction will include participation from KAI-Tion Unicorn Fund No.7. The bonds have yield to maturity of 6%. The bonds will mature on March 13, 2028. The bonds will be 100% converted into 71,056 common shares at a fixed conversion price of KRW 4,222 per share for an equity stake of 1.25%. The conversion period is from March 13, 2026 to March 13, 2028. The payment date of the transaction is March 13, 2025. The securities issued in the transaction are subject to a lock up period of one year. The transaction has been approved by the board of directors of the company. Announcement • Feb 19
TASCOM Co., Ltd., Annual General Meeting, Mar 31, 2025 TASCOM Co., Ltd., Annual General Meeting, Mar 31, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 268, hagui-ro, dongan-gu, gyeonggi-do, anyang South Korea Announcement • Dec 05
TASCOM Co., Ltd. announced that it expects to receive KRW 1.2999991 billion in funding TASCOM Co., Ltd. announced a private placement of 334,190 common shares at a price of KRW 3,890 for gross proceeds of KRW 1,299,999,100 on December 4, 2024. The transaction includes participation from individual investor, Lee Song Margaret Minseon. The transaction has been approved by the board of directors of the company. The payment date of the transaction is December 12, 2024. The securities are under 1 year lockup. New Risk • Nov 25
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risk Market cap is less than US$100m (₩15.7b market cap, or US$11.2m). New Risk • Oct 25
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩13.7b (US$9.87m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Market cap is less than US$10m (₩13.7b market cap, or US$9.87m). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change). Announcement • Aug 13
TASCOM Co.,Ltd. announced that it has received KRW 1.566576 billion in funding from SV Investment Corporation and other investors On August 12, 2022, TASCOM Co.,Ltd. closed the transaction. Announcement • Jun 25
YIDOBIO Inc. (XKON:A336040) entered into a merger agreement to acquire TASCOM CO.,LTD from Lee Seong-dong and other shareholders for KRW 16.6 billion. YIDOBIO Inc. (XKON:A336040) entered into a merger agreement to acquire TASCOM CO.,LTD from Lee Seong-dong and other shareholders for KRW 16.6 billion on June 23, 2021. YIDOBIO will issue KRW 21,000 per share for TASCOM shares as a part of consideration. The consideration represents an exchange ratio of 1:0.4304761 for both preferred and common stock. As a part of the transaction, 1.54 million common shares and class shares of 0.043 will be acquire. Post-closing of the merger YIDOBIO will be the surviving company and TASCOM will be the merged entity. Upon completion of the merger, Leesong Margaret Minseon will become the largest shareholder of the YIDOBIO, and the expected stake of the largest shareholder is 31.53%. Upon completion of the merger, the expected combined stake of Lee Song Margaret Min-sun and Lee Seong-dong is 50.34%. The YIDOBIO board resolution was provided on June 23, 2021. The transaction is subject to shareholders approval from YIDOBIO and TASCOM for which meeting will be held on August 17, 2021. Each party shall, among the necessary government approvals in relation to the Merger. The transaction is expected to be completed by September 23, 2021. Announcement • Feb 20
YIDOBIO Inc., Annual General Meeting, Mar 23, 2021 YIDOBIO Inc., Annual General Meeting, Mar 23, 2021, at 10:00 Korea Standard Time. Announcement • Feb 17
YIDOBIO Inc. announced that it has received KRW 2.759978 billion in funding from Global Trading co.ltd, Korea Medix, Inc. On February 16, 2021, YIDOBIO Inc. (XKON:A336040) closed the transaction. Announcement • Jan 29
YIDOBIO Inc. announced that it expects to receive KRW 2.759978 billion in funding from Global Trading co.ltd, Korea Medix, Inc. and other investors YIDOBIO Inc. (XKON:A336040) announced a private placement of 145,262 convertible preferred shares at a piece of KRW 19,000 per share for gross proceeds of KRW 2,759.978,000 on January 28, 2021. The transaction will include participation from Lee, Yong-jin for 36,842 shares, Lee, Jongmok for 15,789 share, Global Trading co.ltd for 21,053 shares , Seungho Choi for 15,789 shares, Seong, Chiyoon for 20,000 shares, Kim, Ji-eun for 20,000 shares , Eunjoo Bae for 5,263 shares, Park, Jeom-suk for 5,263 shares, and Korea Medix, Inc. for 5,263 shares. The shares will carry a face value of KRW 500 and will be issued at premium. The transaction will take place through third party allotment. The convertible preferred shares will convert into common shares of the company. The conversion period is from February 17, 2021 to February 05, 2030. The transaction will take place through third party allotment .The transaction is expected to close on February 16, 2021. The transaction has been approved by board of directors of the company. Is New 90 Day High Low • Dec 15
New 90-day high: ₩25,800 The company is up 26% from its price of ₩20,550 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is flat over the same period. Is New 90 Day High Low • Nov 13
New 90-day high: ₩20,750 The company is up 16% from its price of ₩17,950 on 14 August 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is down 2.0% over the same period. 
